MedPath

"Efficacy of Intermittent Enteral Nutrition Versus Continuous Administration in Intensive Care"

Not Applicable
Recruiting
Conditions
Gastric Feeding Tube
Feeding Methods
Enteral Nutrition
Critical Care
Interventions
Other: CONTINUOS ENTERAL NUTRITITION (CEN)
Other: INTERMITTENT ENTERAL NUTRITITION (IEN)
Registration Number
NCT05879263
Lead Sponsor
Complejo Hospitalario Universitario de Albacete
Brief Summary

The goal of this clinical trial is to Determine efficacy of intermittent enteral nutrition vs continuous enteral nutrition in adults patients with a nasogastric tube in a intensive care unit.

The main question\[s\] it aims to answer are:

* Reduction of gastrointestinal and respiratory complications

* Evaluate the achievement of the caloric objective Informed consent will be requested from participants who meet the inclusion criteria.

The participants will be randomized into two groups: control group (continuous enteral nutrition) or experimental group (intermittent enteral nutrition) Researchers will compare intermittent enteral nutrition vs continuous to see if there is a reduction in gastrointestinal and respiratory complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
190
Inclusion Criteria
  • Patients admitted to ICU of University General Hospital of Albacete
  • Need for enteral nutrition by nasogastric tube in the first 48 hours
  • Signed informed consent
Exclusion Criteria
  • Insulin dependent diabetic patients
  • Abdominal surgery
  • Dire prognosis

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
CONTINUOUS ENTERAL NUTRITION (CEN)CONTINUOS ENTERAL NUTRITITION (CEN)Administration of Enteral Nutriton (EN) by nasogastric tube during 24 hours, using an infusion pump.
INTERMITTENT ENTERAL NUTRITITION (IEN)INTERMITTENT ENTERAL NUTRITITION (IEN)Administration of Enteral Nutriton (EN) by nasogastric tube in 4 bolus (24h): Duration of the infusion 1hour each shot, using an infusion pump.
Primary Outcome Measures
NameTimeMethod
Respiratory Complicationsduring ICU stay (maximum 15 days)

Respiratory aspiration of gastric content

Gastrointestinal Complicationsduring ICU stay (maximum 15 days)

Digestive intolerance: Diarrhea, vomiting, increased gastric residual volume(GRV)

Secondary Outcome Measures
NameTimeMethod
Achievement of the caloric objectiveduring ICU stay (up to 15 days)

Time in hours to reach caloric goal

Nutritional status: MNAup to two days after admission to the ICU

Measure with:Mini Nutritional Assessment,(MNA) 12-14 points: Normal nutritional status 8-11 points: risk of malnutrition 0-7 points: Malnutrition

ICU StayFrom date of randomization until 100 months

Days of stay in ICU

Nutritional status: Biochemical valuesup to two days after admission to the ICU

Measure with:biochemical values: albumin, prealbumin, total protein

Changes in blood glucoseduring ICU stay (maximum 15 days)

Episodes of hypoglycemia or hyperglycemia

Mortalityuntil the date of death from any cause until 100 months

Percentage of deaths in ICU

Change of type of EN administrationduring ICU stay (maximum 15 days)

Change of EN administration modality

Nutritional status:Glim Criteriaup to two days after admission to the ICU

Measure with: Glim criteria: Phenotypic criteria:Non-volitional weight loss (%) Low BMI (kg/m2)Reduced muscle mass(calf circumference (cm)) Etiologic criteria: Reduced food intake or assimilation. Inflammation

\*Requires at least one phenotypic criterion and one etiologic criterion for the diagnosis of malnutrition

Trial Locations

Locations (1)

Maria Dolores Saiz Vinuesa

🇪🇸

Albacete, Spain

© Copyright 2025. All Rights Reserved by MedPath